The National Institute for Health and Care Excellence (NICE) faced "difficult decisions" when it deemed a breast cancer drug which can extend sufferers lives by "up to six months" was too expensive, according to a health expert.
Dr Hilary Jones told Daybreak the £90,000 price tag per patient would have meant taking funds away from other vital services the NHS provides.
More top news
A drug addict whose sickening attack on a disabled pensioner caused outrage around the world will be sentenced later.
Study suggest that the number of takeaway outlets has significantly increased over the last 20 years, particularly in the poorest areas.
A teachers' union has suggested the number of teachers facing abuse on social media has more than doubled in just 12 months.